Sunday 11 October 2026

One To Watch

Ethris GmbH

Company Overview

Want to Update your Company's Profile?


Latest Ethris GmbH News

Ethris and Lonza link up on spray-dried mRNA vaccines
7 April 2025
Cipla and Ethris partner for the development of mRNA-based therapies
30 December 2022
Former Novartis exec joins Ethris as CMO
4 June 2019
AstraZeneca inks mRNA collaboration with German biotech firm
21 August 2017
More Ethris GmbH news >


Today's issue

The week in pharma: action, reaction and insight – week to October 9, 2026
Biotechnology
The week in pharma: action, reaction and insight – week to October 9, 2026
10 October 2026
Pharmaceutical
Mineralys presents new data for lorundrostat
9 October 2026
Pharmaceutical
Colombian pharma groups sign alliance to fight counterfeit medicines
9 October 2026
Biotechnology
Outlook Therapeutics appoints Greg DiPasquale as CCO
9 October 2026
Biotechnology
Lonza and Onava collaborate to speed AI-native biologics discovery
9 October 2026
Pharmaceutical
FDA approves Teva’s Weltruza for schizophrenia
9 October 2026
Pharmaceutical
Foundayo potential as differentiated oral option for weight and glycemic control
9 October 2026




Copyright © The Pharma Letter 2026

 |  Headless Content Management with Blaze